subject_id=OCCAMS/PS/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/009;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/008;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/008;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/012;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/012;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/015;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/015;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/010;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/011;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/011;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/017;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/017;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/005;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/005;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/023;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/023;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/017;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/005;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/023;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/011;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/047;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/023;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/011;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/047;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/023;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/011;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/036;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/082;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/085;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/086;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/008;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/022;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/004;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/093;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/061;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/120;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/041;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/029;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/029;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/034;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/136;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/049;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/052;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/058;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/006;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/109;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/033;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/008;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/026;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/031;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/022;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/004;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/093;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/029;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/034;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/049;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/052;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/058;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/006;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/109;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/033;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/026;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/031;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/061;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/120;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/041;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/029;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/136;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/008;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/081;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/011;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/022;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/081;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/011;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/022;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/020;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/024;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/025;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/024;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/031;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/183;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/182;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/117;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/046;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/095;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PL/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/056;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/142;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/115;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/020;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/025;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/024;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/117;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/046;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PL/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/056;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/142;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/115;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/024;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/031;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/183;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/182;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/095;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/022;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/074;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/022;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/022;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/074;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/074;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/015;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/026;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/033;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/036;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/041;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/043;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/082;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/085;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/086;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/008;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/015;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/026;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/033;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/041;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/043;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/127;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/127;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/033;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/005;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/008;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/011;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/020;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/069;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/012;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/015;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/021;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/004;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/042;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/048;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/021;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/033;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/005;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/008;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/011;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/004;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/020;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/042;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/048;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/069;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/012;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/015;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/036;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/007;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/108;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/071;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/135;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/043;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/155;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/160;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/027;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/028;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/029;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/036;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/010;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/040;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/007;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/108;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/071;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/026;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/135;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/043;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/138;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/042;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/155;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/160;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/027;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/028;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/045;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/029;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/040;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/026;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/138;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/042;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/045;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/038;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/051;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/002;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/006;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/035;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/037;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/084;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/094;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/062;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/038;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/051;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/002;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/006;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/009;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/027;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/100;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/035;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/037;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/084;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/094;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/062;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/027;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/100;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OCCAMS/AH/065;subject_id=OCCAMS/AH/065;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OCCAMS/AH/065;subject_id=OCCAMS/AH/065;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
